Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Tesch

Showing results (231-240 of 282) with videos related to

Pageof 29
Sort By:
Bone Marrow Transplantation|July 22, 1999
Successful peripheral blood stem cell mobilization with etoposide (VP-16) in patients with relapsed or resistant lymphoma who failed cyclophosphamide mobilizationM Reiser, A Josting, A Draube, et al.
Blood|November 8, 2001
Thoracic positron emission tomography using 18F-fluorodeoxyglucose for the evaluation of residual mediastinal Hodgkin diseaseM R Weihrauch, D Re, K Scheidhauer, et al.
The Journal of Endocrinology|May 29, 2020
Novel mineralocorticoid receptor mechanisms regulate cardiac tissue inflammation in male miceGregory S Y Ong, Timothy J Cole, Gregory H Tesch, et al.
Frontiers in Pharmacology|February 16, 2026
A new Jun amino-terminal kinase inhibitor, KRev-202, inhibits rat ischemic acute injury and the progression to renal fibrosisDavid J Nikolic-Paterson, Greg H Tesch, Elyce Ozols, et al.
International Journal of Experimental Pathology|December 23, 2014
Spleen tyrosine kinase contributes to acute renal allograft rejection in the ratSharmila Ramessur Chandran, Greg H Tesch, Yingjie Han, et al.
Endocrinology|June 2, 2012
Macrophage mineralocorticoid receptor signaling plays a key role in aldosterone-independent cardiac fibrosisLaura A Bienvenu, James Morgan, Amanda J Rickard, et al.
Journal of Virology|January 9, 1999
Expression of epstein-barr virus nuclear antigen 1 is associated with enhanced expression of CD25 in the Hodgkin cell line L428D Kube, M Vockerodt, O Weber, et al.
The American Journal of Pathology|November 5, 1997
Classical Hodgkin's disease. Clinical impact of the immunophenotypeR von Wasielewski, M Mengel, R Fischer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 13, 2000
Gemcitabine in the treatment of refractory Hodgkin's disease: results of a multicenter phase II studyA Santoro, H Bredenfeld, L Devizzi, et al.
American Journal of Nephrology|August 31, 2011
Evaluation of JNK blockade as an early intervention treatment for type 1 diabetic nephropathy in hypertensive ratsAndy K H Lim, Frank Y Ma, David J Nikolic-Paterson, et al.
Pageof 29

Showing results (231-240 of 282) with videos related to

Sort By:
Pageof 29
Bone Marrow Transplantation|July 22, 1999
Successful peripheral blood stem cell mobilization with etoposide (VP-16) in patients with relapsed or resistant lymphoma who failed cyclophosphamide mobilizationM Reiser, A Josting, A Draube, et al.
Blood|November 8, 2001
Thoracic positron emission tomography using 18F-fluorodeoxyglucose for the evaluation of residual mediastinal Hodgkin diseaseM R Weihrauch, D Re, K Scheidhauer, et al.
The Journal of Endocrinology|May 29, 2020
Novel mineralocorticoid receptor mechanisms regulate cardiac tissue inflammation in male miceGregory S Y Ong, Timothy J Cole, Gregory H Tesch, et al.
Frontiers in Pharmacology|February 16, 2026
A new Jun amino-terminal kinase inhibitor, KRev-202, inhibits rat ischemic acute injury and the progression to renal fibrosisDavid J Nikolic-Paterson, Greg H Tesch, Elyce Ozols, et al.
International Journal of Experimental Pathology|December 23, 2014
Spleen tyrosine kinase contributes to acute renal allograft rejection in the ratSharmila Ramessur Chandran, Greg H Tesch, Yingjie Han, et al.
Endocrinology|June 2, 2012
Macrophage mineralocorticoid receptor signaling plays a key role in aldosterone-independent cardiac fibrosisLaura A Bienvenu, James Morgan, Amanda J Rickard, et al.
Journal of Virology|January 9, 1999
Expression of epstein-barr virus nuclear antigen 1 is associated with enhanced expression of CD25 in the Hodgkin cell line L428D Kube, M Vockerodt, O Weber, et al.
The American Journal of Pathology|November 5, 1997
Classical Hodgkin's disease. Clinical impact of the immunophenotypeR von Wasielewski, M Mengel, R Fischer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 13, 2000
Gemcitabine in the treatment of refractory Hodgkin's disease: results of a multicenter phase II studyA Santoro, H Bredenfeld, L Devizzi, et al.
American Journal of Nephrology|August 31, 2011
Evaluation of JNK blockade as an early intervention treatment for type 1 diabetic nephropathy in hypertensive ratsAndy K H Lim, Frank Y Ma, David J Nikolic-Paterson, et al.
Pageof 29